Hepatotoxicity in drug development: detection, significance and solutions.

[1]  G. Lucier,et al.  Growth stimulation followed by growth inhibition in livers of female rats treated with ethinyl estradiol. , 1994, Carcinogenesis.

[2]  E. Wheeldon,et al.  Image analysis of bromodeoxyuridine (BrdU) staining for measurement of S-phase in rat and mouse liver. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[3]  P. Beaune,et al.  Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs. , 1994, Chemical research in toxicology.

[4]  D. Dietrich,et al.  Retrospective assessment of liver cell proliferation via PCNA: a comparison with tritiated thymidine. , 1994, Cancer letters.

[5]  C. Dive,et al.  Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin , 1994, The Journal of cell biology.

[6]  P. Johns.  An Examination of the Drug Review Process Within the United States , 1994 .

[7]  J. DiMasi.  Risks, regulation, and rewards in new drug development in the United States. , 1994, Regulatory toxicology and pharmacology : RTP.

[8]  I. Shaw,et al.  Mechanisms of non-genotoxic carcinogenesis. , 1994, Trends in pharmacological sciences.

[9]  R. Bendele.  Safety Assessment Programs for U.S. Regulatory Agencies: A Perspective of Requirements and Compliance , 1994, Toxicologic pathology.

[10]  S Kettle,et al.  Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis , 1994, Human & experimental toxicology.

[11]  I. Purchase.  Current Knowledge of Mechanisms of Carcinogenicity: Genotoxins versus Non-genotoxins , 1994, Human & experimental toxicology.

[12]  R. Maronpot,et al.  Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats. , 1993, Environmental health perspectives.

[13]  Robert J. Scheuplein.  Use of cell proliferation data in cancer risk assessment: FDA view. , 1993, Environmental health perspectives.

[14]  R. Maronpot,et al.  Concepts, labeling procedures, and design of cell proliferation studies relating to carcinogenesis. , 1993, Environmental health perspectives.

[15]  K Brendel,et al.  Correlation of metabolism, covalent binding and toxicity for a series of bromobenzene derivatives using rat liver slices in vitro. , 1993, Chemico-biological interactions.

[16]  W. Trager,et al.  Bioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[17]  B. K. Park,et al.  An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro. Studies with human and rat liver microsomes. , 1993, Biochemical pharmacology.

[18]  P. Grasso,et al.  The Use of the Dog in Toxicity Tests on Pharmaceutical Compounds , 1993, Human & experimental toxicology.

[19]  T. Myers,et al.  Immunochemical detection of liver protein adducts of the nonsteroidal antiinflammatory drug diclofenac. , 1993, Chemical research in toxicology.

[20]  G Zbinden,et al.  The concept of multispecies testing in industrial toxicology. , 1993, Regulatory toxicology and pharmacology : RTP.

[21]  F. Ballet,et al.  Effect of bile acids on intracellular calcium in isolated rat hepatocyte couplets. , 1993, Biochemical pharmacology.

[22]  I. Kuntz.  Structure-Based Strategies for Drug Design and Discovery , 1992, Science.

[23]  R. H. Gray,et al.  Chemical Structure-Activity Relationships: Peroxisome Proliferation and Lipid Regulation in Rats , 1992 .

[24]  C. Klaassen,et al.  UDP-glucuronosyltransferase inducers reduce thyroid hormone levels in rats by an extrathyroidal mechanism. , 1992, Toxicology and applied pharmacology.

[25]  L. Azároff,et al.  Phenobarbital induction of cytochrome P-450 gene expression. , 1992, The Biochemical journal.

[26]  R. Houghten,et al.  Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery , 1991, Nature.

[27]  G Zbinden,et al.  Predictive value of animal studies in toxicology. , 1991, Regulatory toxicology and pharmacology : RTP.

[28]  M. Orme.  Animal Toxicity Studies: Their Relevance for Man , 1991 .

[29]  B. Lake,et al.  Peroxisome proliferation and nongenotoxic carcinogenesis: Commentary on a symposium , 1991 .

[30]  R. Edwards,et al.  Species variation in the response of the cytochrome P-450-dependent monooxygenase system to inducers and inhibitors. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.

[31]  O. Linet,et al.  Early Phase Drug Evaluation in Man , 1990 .

[32]  P. Maurel,et al.  Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. , 1990, Gastroenterology.

[33]  J. Kapeghian,et al.  The role of experimental toxicology in safety evaluation: Challenges facing the pharmaceutical industry , 1990, Medicinal research reviews.

[34]  R. Michael McClain,et al.  The Significance of Hepatic Microsomal Enzyme Induction and Altered Thyroid Function in Rats: Implications for Thyroid Gland Neoplasia , 1989, Toxicologic pathology.

[35]  D. Kornbrust,et al.  Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits. , 1989, The Journal of pharmacology and experimental therapeutics.

[36]  R. Birge,et al.  Immunochemical analysis of acetaminophen covalent binding to proteins. Partial characterization of the major acetaminophen-binding liver proteins. , 1988, Biochemical pharmacology.

[37]  T. Monks,et al.  Reactive intermediates and their toxicological significance. , 1988, Toxicology.

[38]  S. Prahalada,et al.  Preclinical evaluation of lovastatin. , 1988, The American journal of cardiology.

[39]  Steven D. Cohen,et al.  Immunochemical detection of acetaminophen-bound liver proteins. , 1987, Biochemical pharmacology.

[40]  M F Balandrin,et al.  Natural plant chemicals: sources of industrial and medicinal materials. , 1985, Science.

[41]  W. Bursch,et al.  Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. , 1984, Carcinogenesis.

[42]  A. Demain.  New applications of microbial products. , 1983, Science.

[43]  Curtis D. Klaassen,et al.  Casarett and Doull's Toxicology. The Basic Science of Poisons , 1981 .

[44]  R. Schulte‐Hermann.  Induction of liver growth by xenobiotic compounds and other stimuli. , 1974, CRC critical reviews in toxicology.

[45]  J. Huff,et al.  Carcinogenicity of TCDD: experimental, mechanistic, and epidemiologic evidence. , 1994, Annual review of pharmacology and toxicology.

[46]  U. Boelsterli,et al.  Specific targets of covalent drug-protein interactions in hepatocytes and their toxicological significance in drug-induced liver injury. , 1993, Drug metabolism reviews.

[47]  M. Maratrat,et al.  Effect of tauroursodeoxycholate on actin filament alteration induced by cholestatic agents. A study in isolated rat hepatocyte couplets. , 1993, Journal of hepatology.

[48]  J. Dean,et al.  The integration of investigative toxicology in the drug discovery process , 1993, Biology of the cell.

[49]  J. Claude,et al.  Actin filament alteration as a potential marker for cholestasis: a study in isolated rat hepatocyte couplets. , 1992, Toxicology.

[50]  S. Green.  Nuclear receptors and chemical carcinogenesis. , 1992, Trends in pharmacological sciences.

[51]  L. Poellinger,et al.  The dioxin and peroxisome proliferator-activated receptors: nuclear receptors in search of endogenous ligands. , 1992, Trends in pharmacological sciences.

[52]  W. Bursch,et al.  Cell death by apoptosis and its protective role against disease. , 1992, Trends in pharmacological sciences.

[53]  J. Hinson,et al.  Role of covalent and noncovalent interactions in cell toxicity: effects on proteins. , 1992, Annual review of pharmacology and toxicology.

[54]  T. Goldsworthy,et al.  Guidelines for measuring chemically induced cell proliferation in specific rodent target organs. , 1991, Progress in clinical and biological research.

[55]  Shih-Png Ye,et al.  Stimulation of hepatocyte DNA synthesis by ethinyl estradiol. , 1991, Progress in clinical and biological research.

[56]  P. Pearson,et al.  Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. , 1990, Annual review of pharmacology and toxicology.

[57]  A. J. Gandolfi,et al.  Precision-cut liver slices: an in vitro system for profiling potential hepatotoxicants , 1990 .

[58]  E. Lock,et al.  Biochemical mechanisms of induction of hepatic peroxisome proliferation. , 1989, Annual review of pharmacology and toxicology.

[59]  S. Walker,et al.  Predicting the safety of medicines from animal toxicity tests. I. Rodents alone. , 1987, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[60]  S. Walker,et al.  Predicting the safety of medicines from animal toxicity tests. II. Rodents and non-rodents. , 1987, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[61]  P. Beaune,et al.  Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[62]  A. Guillouzo,et al.  Isolated and cultured hepatocytes , 1986 .

[63]  B. H. Ch. Stricker,et al.  Drug-induced Hepatic Injury , 1985 .

[64]  Reddy Jk,et al.  Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans , 1983 .